Tag Cloud Results
Results found matching tag QIAGEN
From the News
QIAGEN receives SFDA approval for marketing of healthcare HPV testing in China and expand access to ...
QIAGEN Reports Results for Third Quarter 2012
QIAGEN startet Initiative zur Steigerung der Effizienz und Verbesserung der Ressourcenallokation
QIAGEN to develop new companion diagnostic for compound in clinical trials for blood cancers
QIAGEN completes acquisition of Cellestis Limited
QIAGEN and Pfizer partner to develop companion diagnostic for novel compound in global clinical trials ...
QIAGEN welcomes approval of scheme by supreme court of Victoria
QIAGEN opens Taiwan subsidiary to further expand presence in Asia
QIAGEN completes second U.S. submission for companion diagnostic to guide treatment decisions in colorectal ...
QIAGEN welcomes approval of Scheme by CELLESTIS Shareholders
QIAGEN launches Multiplex PCR Plus Kit
QIAGEN updates proposal to acquire Cellestis Limited
QIAGEN reaches agreement to buy 61% stake in Ipsogen, plans to fully acquire leader in oncology molecular ...
QIAGEN Added to Russell 1000 and Russell 3000 Indexes
QIAGEN makes proposal to fully acquire Ipsogen, further expanding leadership in oncology molecular diagnostics
QIAGEN launches qBiomarker Somatic Mutation PCR Array System
QIAGEN reaches milestone of 75 million deliveries of HPV tests
QIAGEN & Merck Launch Africa’s First Comprehensive Cervical Cancer Prevention Program Incorporating ...
QIAGEN to acquire Cellestis Limited (CST:AU)
QIAGEN launches kit for DNA quantification in forensic samples
QIAGEN launches ScreenGel software for QIAxcel® multicapillary gel electrophoresis systems
Qiagen has the best relative performance in the Life Sciences Tools & Services Industry
QIAGEN reports full-year and Fourth Quarter 2010 results
QIAGEN establishes subsidiary in India to accelerate expansion
Qiagen starts year with two deals
From the News
QIAGEN receives SFDA approval for marketing of healthcare HPV testing in China and expand access to ...
QIAGEN Reports Results for Third Quarter 2012
QIAGEN startet Initiative zur Steigerung der Effizienz und Verbesserung der Ressourcenallokation
QIAGEN to develop new companion diagnostic for compound in clinical trials for blood cancers
QIAGEN completes acquisition of Cellestis Limited
QIAGEN and Pfizer partner to develop companion diagnostic for novel compound in global clinical trials ...
QIAGEN welcomes approval of scheme by supreme court of Victoria
QIAGEN opens Taiwan subsidiary to further expand presence in Asia
QIAGEN completes second U.S. submission for companion diagnostic to guide treatment decisions in colorectal ...
QIAGEN welcomes approval of Scheme by CELLESTIS Shareholders
QIAGEN launches Multiplex PCR Plus Kit
QIAGEN updates proposal to acquire Cellestis Limited
QIAGEN reaches agreement to buy 61% stake in Ipsogen, plans to fully acquire leader in oncology molecular ...
QIAGEN Added to Russell 1000 and Russell 3000 Indexes
QIAGEN makes proposal to fully acquire Ipsogen, further expanding leadership in oncology molecular diagnostics
QIAGEN launches qBiomarker Somatic Mutation PCR Array System
QIAGEN reaches milestone of 75 million deliveries of HPV tests
QIAGEN & Merck Launch Africa’s First Comprehensive Cervical Cancer Prevention Program Incorporating ...
QIAGEN to acquire Cellestis Limited (CST:AU)
QIAGEN launches kit for DNA quantification in forensic samples
QIAGEN launches ScreenGel software for QIAxcel® multicapillary gel electrophoresis systems
Qiagen has the best relative performance in the Life Sciences Tools & Services Industry
QIAGEN reports full-year and Fourth Quarter 2010 results
QIAGEN establishes subsidiary in India to accelerate expansion
Qiagen starts year with two deals


